Sequential chemoradiotherapy versus induction chemotherapy plus concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicentre, open-label, non-inferiority, randomised, phase 3 trial

被引：0
|
作者：
Hu, Chao-su
Xue, Fen
Ou, Dan
Xie, Congying
Lin, Shaojun
Li, Jingao
Chen, Xiaozhong
Zhang, Fuzheng
Ying, Hongmei
Lu, Xueguan
Shen, Chunying
Xu, Tingting
Ou, Xiaomin
Zhou, Xin
Du, Chengrun
Li, Weiwei
He, Xiayun
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
[3] Fujian Prov Canc Hosp, Fuzhou, Fujian, Peoples R China
[4] Jiangxi Canc Hosp, Dept Radiat Oncol, Nanchang, Jiangxi, Peoples R China
[5] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[6] Jiangnan Univ, Affiliated Hosp, Wuxi, Jiangsu, Peoples R China
[7] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6075
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
    Sun, Ying
    Li, Wen-Fei
    Chen, Nian-Yong
    Zhang, Ning
    Hu, Guo-Qing
    Xie, Fang-Yun
    Sun, Yan
    Chen, Xiao-Zhong
    Li, Jin-Gao
    Zhu, Xiao-Dong
    Hu, Chao-Su
    Xu, Xiang-Ying
    Chen, Yuan-Yuan
    Hu, Wei-Han
    Guo, Ling
    Mo, Hao-Yuan
    Chen, Lei
    Mao, Yan-Ping
    Sun, Rui
    Ai, Ping
    Liang, Shao-Bo
    Long, Guo-Xian
    Zheng, Bao-Min
    Feng, Xing-Lai
    Gong, Xiao-Chang
    Li, Ling
    Shen, Chun-Ying
    Xu, Jian-Yu
    Guo, Ying
    Chen, Yu-Ming
    Zhang, Fan
    Lin, Li
    Tang, Ling-Long
    Liu, Meng-Zhong
    Ma, Jun
    LANCET ONCOLOGY, 2016, 17 (11): : 1509 - 1520
  • [2] Induction chemotherapy plus radiotherapy alone versus cisplatin-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: An open-label, non-inferiority, randomized phase 3 trial.
    Chen, MingYuan
    Huang, Peiyu
    Chen, Xuyin
    Ding, Xi
    Ling, Guo
    Mo, Hao-Yuan
    Duan, Chongyang
    Ling, Li
    Zou, Xiong
    Liu, You-Ping
    You, Rui
    Xie, Yulong
    Cao, Jingyu
    Liu, Sihan
    Wang, Zimeng
    Yang, Qi
    Qiu, Fang
    Hua, Yijun
    Cao, Kajia
    Luo, Dong-Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] INDUCTION CHEMOTHERAPY PLUS CONCURRENT CHEMORADIOTHERAPY VERSUS CONCURRENT CHEMORADIOTHERAPY ALONE IN PATIENTS WITH LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA: PRELIMINARY RESULTS OF A PHASE 3 MULTICENTRE RANDOMISED CONTROLLED TRIAL
    Ma, J.
    Chen, N. -Y.
    Zhang, N.
    Hu, G. -Q.
    Sun, Y.
    Chen, X. -Z.
    Li, J. -G.
    Zhu, X. -D.
    Hu, C. -S.
    Xu, X. -Y.
    Sun, Y.
    Xie, F. -Y.
    Hua, W. -H.
    Guo, L.
    Mo, H. -Y.
    Guo, Y.
    Chen, L.
    Li, W. -F.
    Liu, M. -Z.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E3 - E4
  • [4] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
    Chen, Lei
    Hu, Chao-Su
    Chen, Xiao-Zhong
    Hu, Guo-Qing
    Cheng, Zhi-Bin
    Sun, Yan
    Li, Wei-Xiong
    Chen, Yuan-Yuan
    Xie, Fang-Yun
    Liang, Shao-Bo
    Chen, Yong
    Xu, Ting-Ting
    Li, Bin
    Long, Guo-Xian
    Wang, Si-Yang
    Zheng, Bao-Min
    Guo, Ying
    Sun, Ying
    Mao, Yan-Ping
    Tang, Ling-Long
    Chen, Yu-Ming
    Liu, Meng-Zhong
    Ma, Jun
    LANCET ONCOLOGY, 2012, 13 (02): : 163 - 171
  • [5] Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial
    Tang, Lin-Quan
    Chen, Dong-Ping
    Guo, Ling
    Mo, Hao-Yuan
    Huang, Ying
    Guo, Shan-Shan
    Qi, Bin
    Tang, Qing-Nan
    Wang, Pan
    Li, Xiao-Yun
    Li, Ji-Bin
    Liu, Qing
    Gao, Yuan-Hong
    Xie, Fang-Yun
    Liu, Li-Ting
    Li, Yang
    Liu, Sai-Lan
    Xie, Hao-Jun
    Liang, Yu-Jing
    Sun, Xue-Song
    Yan, Jin-Jie
    Wu, Yi-Shan
    Luo, Dong-Hua
    Huang, Pei-Yu
    Xiang, Yan-Qun
    Sun, Rui
    Chen, Ming-Yuan
    Lv, Xing
    Wang, Lin
    Xia, Wei-Xiong
    Zhao, Chong
    Cao, Ka-Jia
    Qian, Chao-Nan
    Guo, Xiang
    Hong, Ming-Huang
    Nie, Zhi-Qiang
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    LANCET ONCOLOGY, 2018, 19 (04): : 461 - 473
  • [6] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
    Cao, Su-Mei
    Yang, Qi
    Guo, Ling
    Mai, Hai-Qiang
    Mo, Hao-Yuan
    Cao, Ka-Jia
    Qian, Chao-Nan
    Zhao, Chong
    Xiang, Yan-Qun
    Zhang, Xiu-Ping
    Lin, Zhi-Xiong
    Li, Wei-Xiong
    Liu, Qing
    Qiu, Fang
    Sun, Rui
    Chen, Qiu-Yan
    Huang, Pei-Yu
    Luo, Dong-Hua
    Hua, Yi-Jun
    Wu, Yi-Shan
    Lv, Xing
    Wang, Lin
    Xia, Wei-Xiong
    Tang, Lin-Quan
    Ye, Yan-Fang
    Chen, Ming-Yuan
    Guo, Xiang
    Hong, Ming-Huang
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 14 - 23
  • [7] A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma
    Huang, Pei-Yu
    Cao, Ka-Jia
    Guo, Xiang
    Mo, Hao-Yuan
    Guo, Ling
    Xiang, Yan-Qun
    Deng, Man-Quan
    Qiu, Fang
    Cao, Su-Mei
    Guo, Ying
    Zhang, Li
    Li, Ning-Wei
    Sun, Rui
    Chen, Qiu-Yan
    Luo, Dong-Hua
    Hua, Yi-Jun
    Mai, Hai-Qiang
    Hong, Ming-Huang
    ORAL ONCOLOGY, 2012, 48 (10) : 1038 - 1044
  • [8] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Chen, Ming-Yuan
    Cao, Su-Mei
    Yang, Qi
    Guo, Ling
    Mai, Hai-Qiang
    Mo, Hao-Yuan
    Cao, Ka-Jia
    Qian, Chao-Nan
    Zhao, Chong
    Yanqun, Xiang
    Zhang, Xiu-Ping
    Lin, Zhi-Xiong
    Li, Wei-Xiong
    Guo, Xiang
    Hong, Ming-Huang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial
    Wang, Yan
    Wang, Chengtao
    He, Shasha
    Bai, Li
    Kong, Fei
    Wang, Siyang
    Cui, Lei
    Qin, Qiang
    Yang, Yunying
    Xiao, Wei
    Zhu, Meiyan
    Zhang, Zeyu
    Lai, Yulin
    Bao, Wenjing
    Peng, Zhenwei
    Chen, Yong
    ECLINICALMEDICINE, 2022, 53
  • [10] Induction plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma
    Chen, Lin
    Li, Kunpeng
    Li, Qingjie
    Ji, Pengjie
    Huang, Chenglong
    Tang, Linglong
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
12345